Esophageal adenocarcinoma (EAC) remains difficult to treat, particularly within tumor hypoxic niches that stabilize HIF1α and drive therapeutic resistance and metastasis [21,31,32,33]. The gene discussed is HIF1A; the disease is neoplasm.